Financhill
Sell
5

NUWE Quote, Financials, Valuation and Earnings

Last price:
$1.82
Seasonality move :
-17.37%
Day range:
$1.80 - $1.90
52-week range:
$1.71 - $60.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
3.33x
Volume:
34.9K
Avg. volume:
4.3M
1-year change:
-96.95%
Market cap:
$13M
Revenue:
$8.7M
EPS (TTM):
-$79.42

Analysts' Opinion

  • Consensus Rating
    Nuwellis, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.00, Nuwellis, Inc. has an estimated upside of 24605.91% from its current price of $1.87.
  • Price Target Downside
    According to analysts, the lowest downside price target is $13.00 representing 100% downside risk from its current price of $1.87.

Fair Value

  • According to the consensus of 1 analyst, Nuwellis, Inc. has 24605.91% upside to fair value with a price target of $13.00 per share.

NUWE vs. S&P 500

  • Over the past 5 trading days, Nuwellis, Inc. has underperformed the S&P 500 by -15.7% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Nuwellis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Nuwellis, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Nuwellis, Inc. reported revenues of $2.2M.

Earnings Growth

  • Nuwellis, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Nuwellis, Inc. reported earnings per share of $0.56.
Enterprise value:
10.3M
EV / Invested capital:
--
Price / LTM sales:
0.50x
EV / EBIT:
--
EV / Revenue:
1.26x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.09x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$4.8M
Return On Assets:
-203.12%
Net Income Margin (TTM):
-202.83%
Return On Equity:
-1004.06%
Return On Invested Capital:
-773.58%
Operating Margin:
-121.65%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $8.7M $9M $8.2M $2.4M $2.2M
Gross Profit $4.9M $5.7M $4.8M $1.7M $1.4M
Operating Income -$18.6M -$12.2M -$11.1M -$1.5M -$2.7M
EBITDA -$18.2M -$11.9M -$10.8M -$1.5M -$2.7M
Diluted EPS -$567.64 -$116.60 -$79.42 $1.74 $0.56
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $32.7M $16.4M $9.6M $5.5M $7.2M
Total Assets $34.1M $18.4M $11.4M $6.7M $8M
Current Liabilities $3.8M $3.6M $3M $2.7M $3.5M
Total Liabilities $4.1M $4.4M $3.6M $3.5M $4.1M
Total Equity $30M $14M $7.8M $3.2M $3.9M
Total Debt $60K $845K $609K $368K $128K
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$18.3M -$10.8M -$9.3M -$2.5M -$3.1M
Cash From Investing $15.1M -$1K -$125K $16K -$98K
Cash From Financing $11.5M $7.8M $10.6M $3.3M $1.9M
Free Cash Flow -$18.6M -$10.8M -$9.4M -$2.5M -$3.2M
NUWE
Sector
Market Cap
$13M
$25.2M
Price % of 52-Week High
3.07%
49.83%
Dividend Yield
0%
0%
Shareholder Yield
-45.28%
-1.77%
1-Year Price Total Return
-96.95%
-21.9%
Beta (5-Year)
-0.106
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $2.13
200-day SMA
Sell
Level $8.81
Bollinger Bands (100)
Sell
Level 2.01 - 3.31
Chaikin Money Flow
Buy
Level 895.7K
20-day SMA
Sell
Level $2.75
Relative Strength Index (RSI14)
Sell
Level 39.04
ADX Line
Sell
Level 36.11
Williams %R
Buy
Level -94.8903
50-day SMA
Sell
Level $2.36
MACD (12, 26)
Buy
Level 0.38
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 1.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-7.7344)
Sell
CA Score (Annual)
Level (-5.179)
Buy
Beneish M-Score (Annual)
Level (-210.007)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.7477)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Stock Forecast FAQ

In the current month, NUWE has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NUWE average analyst price target in the past 3 months is $13.00.

  • Where Will Nuwellis, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Nuwellis, Inc. share price will rise to $13.00 per share over the next 12 months.

  • What Do Analysts Say About Nuwellis, Inc.?

    Analysts are divided on their view about Nuwellis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nuwellis, Inc. is a Sell and believe this share price will drop from its current level to $13.00.

  • What Is Nuwellis, Inc.'s Price Target?

    The price target for Nuwellis, Inc. over the next 1-year time period is forecast to be $13.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is NUWE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Nuwellis, Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of NUWE?

    You can purchase shares of Nuwellis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nuwellis, Inc. shares.

  • What Is The Nuwellis, Inc. Share Price Today?

    Nuwellis, Inc. was last trading at $1.82 per share. This represents the most recent stock quote for Nuwellis, Inc.. Yesterday, Nuwellis, Inc. closed at $1.87 per share.

  • How To Buy Nuwellis, Inc. Stock Online?

    In order to purchase Nuwellis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
23
CAR alert for Feb 20

Avis Budget Group, Inc. [CAR] is down 0.3% over the past day.

Buy
75
HYMC alert for Feb 20

Hycroft Mining Holding Corp. [HYMC] is down 2.47% over the past day.

Sell
1
EPAM alert for Feb 20

EPAM Systems, Inc. [EPAM] is down 0.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock